A pair of San Antonio biotech companies, BioBridge Global and StemBioSys Inc., have agreed to expand the scope of their collaborative relationship in an effort to bring a new source of stem cells to the research market.
Recent Posts
- Youthful Brain Stem Cells Linked to Autism and Brain Cancer
- The compassionate team behind CAR T cancer breakthroughs
- JPM25: Bayer moves allogeneic cell therapy into phase 3 Parkinson’s trial
- Autologous Implants: The New Hope for Spinal Cord Injury Treatment
- Correcting Genetic Spelling Errors With Next-Generation Crispr
- Automated iPS cell production to start in Japan in April